Synthesis, analysis and cytotoxic evaluation of some hydroxypyridinone derivatives on HeLa and K562 cell lines
- PMID: 24019828
- PMCID: PMC3764670
Synthesis, analysis and cytotoxic evaluation of some hydroxypyridinone derivatives on HeLa and K562 cell lines
Abstract
A range of iron bidentae ligands containing the chelating moiety 3- hydroxypyridin-4-ones (HPOs) have been synthesized via a single or a three-step synthetic pathway. In the single-step reaction, maltol was directly reacted by suitable primary amine and in the second synthetic method; benzylated maltol was reacted with related amines to give 1-substuted-2-methyl-3-benzyloxypyridin-4-one derivatives. Finally, removal of the benzyl group under acidic conditions was performed by catalytic hydrogenation to yield the favored bidentate chelators as HCl salt. The partition coefficient of the free ligands and their iron (III) complexes between an aqueous phase buffered at pH 7.4 and 1-octanol were also determined. The cytotoxic effects of these iron chelators against HeLa and K562 cell lines were evaluated using MTT assay and the results showed that cytotoxicity was closely related to the lipophilicity of compounds so that the most lipophilic compound (4g) revealed the highest activity and compound 4e as a more hydrophilic agent (Kpart; 0.05) showed the lowest cytotoxic effect.
Keywords: 3-Hydroxypyridin-4-ones; Cytotoxicity; HeLa and K562 cells; Iron chelating agents; Lipophilicity.
Figures







Similar articles
-
Synthesis and biological evaluation of bidentate 3-hydroxypyridin-4-ones iron chelating agents.Res Pharm Sci. 2011 Jul;6(2):117-22. Res Pharm Sci. 2011. PMID: 22224095 Free PMC article.
-
Synthesis of polymers containing 3-hydroxypyridin-4-one bidentate ligands for treatment of iron overload.Res Pharm Sci. 2015 Jul-Aug;10(4):364-77. Res Pharm Sci. 2015. PMID: 26600863 Free PMC article.
-
Structure-function investigation of the interaction of 1- and 2-substituted 3-hydroxypyridin-4-ones with 5-lipoxygenase and ribonucleotide reductase.J Biol Chem. 2001 Dec 28;276(52):48814-22. doi: 10.1074/jbc.M109551200. Epub 2001 Oct 15. J Biol Chem. 2001. PMID: 11602611
-
The development of iron chelating drugs.Baillieres Clin Haematol. 1989 Apr;2(2):257-92. doi: 10.1016/s0950-3536(89)80018-6. Baillieres Clin Haematol. 1989. PMID: 2660929 Review.
-
New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications.Int J Mol Sci. 2021 May 24;22(11):5546. doi: 10.3390/ijms22115546. Int J Mol Sci. 2021. PMID: 34074010 Free PMC article. Review.
Cited by
-
Preparation of 3-benzyloxy-2-pyridinone functional linkers: Tools for the synthesis of 3,2-hydroxypyridinone (HOPO) and HOPO/hydroxamic acid chelators.Tetrahedron. 2015 Dec 8;71(49):9271-9281. doi: 10.1016/j.tet.2015.10.031. Tetrahedron. 2015. PMID: 26640304 Free PMC article.
-
Synthesis and cytotoxic evaluation of some new 3-(2-(2-phenylthiazol-4-yl) ethyl)-quinazolin-4(3H) one derivatives with potential anticancer effects.Res Pharm Sci. 2017 Aug;12(4):290-298. doi: 10.4103/1735-5362.212046. Res Pharm Sci. 2017. PMID: 28855940 Free PMC article.
-
Salvage Structures, Known as Iron Chelating Agents, Acquired from the Nature and Matured in the Labs.Curr Med Chem. 2025;32(21):4225-4258. doi: 10.2174/0109298673264118231228042816. Curr Med Chem. 2025. PMID: 40855809 Review.
References
-
- Crichton RR, Ward RJ. Iron metabolism-new perspectives in view. Biochemistry. 1992;31:11255–11264. - PubMed
-
- Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radical Biol Med. 1996;20:553–566. - PubMed
-
- Weinberg ED. Iron, asbestos, and carcinogenicity. Lancet. 1989;1:1399–1400. - PubMed
-
- Green DA, Antholine WE, Wong SJ, Richardson DR, Chitambar CR. Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: effect on the R2 subunit of ribonucleotide reductase. Clin Cancer Res. 2001;7:3574–3579. - PubMed
-
- Fukuchi K, Tomoyasu S, Tsuruoka N, Gomi K. Iron deprivation-induced apoptosis in HL-60 cells. FEBS Lett. 1994;350:139–142. - PubMed
LinkOut - more resources
Full Text Sources